We found that RPS6KA1 expression differed between the steatosis and NASH groups, with all AUCs being > 0.7, whereas LMCD1 expression differed only in the steatosis group. This evidence concerns the gene RPS6KA1 and metabolic dysfunction-associated steatohepatitis.